⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

VIP

Published Research

PubMed-indexed studies for VIP

Research

Vasoactive Intestinal Peptide (VIP) Nanoparticles for Diagnostics and for Controlled and Targeted Drug Delivery.

Advances in protein chemistry and structural biology 2015
View on PubMed →
Research

The vasoactive intestinal peptide (VIP) receptor: recent data and hypothesis.

Biochimie 1988
View on PubMed →
Research

The role of vasoactive intestinal peptide in pulmonary diseases.

Life sciences 2023
View on PubMed →
Research

Vasoactive Intestinal Peptide (VIP) Protects Nile Tilapia (Oreochromis niloticus) against Streptococcus agalatiae Infection.

International journal of molecular sciences 2022
View on PubMed →
Research

Vasoactive intestinal peptide (VIP), a putative neurotransmitter of nonadrenergic, noncholinergic (NANC) inhibitory innervation and its relevance to therapy.

Journal of veterinary pharmacology and therapeutics 1989
View on PubMed →
Research

Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetes.

Frontiers in endocrinology 2022
View on PubMed →

Research-Grade VIP

YPB.281
VIP10 (10mg)
$80.00
⚠️ For laboratory research only. Not for human use.